http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060020664-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6a5d00d580b88a56cd983a1803f966 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate | 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c01f794bab3ed73a6d53ec55b7d987 |
| publicationDate | 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20060020664-A |
| titleOfInvention | Acenapine for the treatment of schizophrenia in patients who are overweight or prone to overweight |
| abstract | The present invention relates to the use of acenapine for the manufacture of a medicament for such treatment, due to the presence of risk factors in overweight patients, patients who have shown weight gain due to antipsychotics, or in diseases where overweight is also a risk factor or Antipsychotics are administered to patients in need of preventing weight gain due to the presence of other weight gain factors to provide a means for treating schizophrenia. |
| priorityDate | 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.